Cynthia Cetani
Compliance Officer at INDIVIOR PLC
Net worth: 4 M $ as of 2024-03-30
Profile
Cynthia Cetani is currently the Chief Compliance & Integrity Officer at Indivior PLC since 2018.
Prior to this, she worked as the Head-Compliance Operations & Group Integrity at Novartis AG and as the Chief Compliance Officer at Novartis Pharmaceuticals Corp.
Ms. Cetani is a graduate of Rider University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INDIVIOR PLC
0.14% | 2024-02-29 | 187,810 ( 0.14% ) | 4 M $ | 2024-03-30 |
Cynthia Cetani active positions
| Companies | Position | Start |
|---|---|---|
| INDIVIOR PLC | Compliance Officer | 2018-09-30 |
Former positions of Cynthia Cetani
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Compliance Officer | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Compliance Officer | - |
Training of Cynthia Cetani
| Rider University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INDIVIOR PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Cynthia Cetani
